Home › Funds › Krensavage Asset Management, LLC › JAZZ

Krensavage Asset Management, LLC position in JAZZ

JAZZ PHARMACEUTICALS PLC SHS USD · Health Care

Krensavage Asset Management, LLC reported holding 167,816 shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) in its Q2 2026 13F filing — a position valued at US$40.4M, representing 15.36% of its reported portfolio and ranking #2 among its reported holdings. Krensavage Asset Management, LLC has disclosed JAZZ holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)167.82K sh
Reported value held$40.44M
Portfolio Weight15.36%
First reportedQ4 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Krensavage Asset Management, LLC's JAZZ position evolved

Krensavage Asset Management, LLC first disclosed a stake in JAZZ in Q4 2023 at 100,000 shares (US$12.3M). The position peaked in Q2 2026 at 167,816 shares, worth US$40.4M. Across 11 filings, Krensavage Asset Management, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 167,816 shares valued at US$40.4M. Notable position changes include a 64% increase in Q2 2025 (shares rose 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 100.00K $12.30M New
Q1 2024 101.15K $12.18M Add
Q2 2024 109.08K $11.64M Add
Q3 2024 110.26K $12.28M Add
Q4 2024 105.80K $13.03M Reduce
Q1 2025 100.70K $12.50M Reduce
Q2 2025 164.82K $17.49M Add
Q3 2025 167.82K $22.12M Add
Q4 2025 167.82K $28.53M Hold
Q1 2026 167.82K $31.73M Hold
Q2 2026 167.82K $40.44M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JAZZ and 13F data

JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) is a Health Care company. 44 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JAZZ

All JAZZ fund holders →

FAQ

How long has Krensavage Asset Management, LLC held JAZZ?

Krensavage Asset Management, LLC has disclosed JAZZ holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Krensavage Asset Management, LLC's current position in JAZZ?

As of Q2 2026, Krensavage Asset Management, LLC holds 167.82K shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD), valued at $40.44M, representing 15.36% of its reported portfolio and ranking #2.

Has Krensavage Asset Management, LLC been buying or selling JAZZ?

In the latest 13F filing (Q2 2026), Krensavage Asset Management, LLC held unchanged its position in JAZZ. The position peaked in Q2 2026 at 167.82K shares.

Which other funds hold JAZZ?

Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.